Cargando…
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data
Coronary artery disease (CAD) remains one of the most important causes of morbidity and mortality worldwide, and revascularization through percutaneous coronary interventions (PCI) significantly improves survival. In this setting, poor glycaemic control, regardless of diabetes, has been associated w...
Autores principales: | Nusca, Annunziata, Piccirillo, Francesco, Bernardini, Federico, De Filippis, Aurelio, Coletti, Federica, Mangiacapra, Fabio, Ricottini, Elisabetta, Melfi, Rosetta, Gallo, Paolo, Cammalleri, Valeria, Napoli, Nicola, Ussia, Gian Paolo, Grigioni, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266811/ https://www.ncbi.nlm.nih.gov/pubmed/35806265 http://dx.doi.org/10.3390/ijms23137261 |
Ejemplares similares
-
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
por: Nusca, Annunziata, et al.
Publicado: (2021) -
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
por: Bernardini, Federico, et al.
Publicado: (2023) -
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)
por: Mangiacapra, Fabio, et al.
Publicado: (2021) -
Invasive Assessment of Coronary Microvascular Function
por: Mangiacapra, Fabio, et al.
Publicado: (2021) -
Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets
por: Piccirillo, Francesco, et al.
Publicado: (2023)